Onetouch Verio (Tm) Iq Blood Glucose Monitoring System
Glucose Dehydrogenase, Glucose. 510(k) K110637, from Cilag GmbH International (Zug, CH). Product code LFR, class 2.
As of Nov 20, 2026, K110637 is an FDA 510(k) held by Cilag GmbH International, substantially equivalent on Sep 7, 2011 after 187 days, with 1 recall tied to it in FDA's recall database.
- Review time: 187 days
- Recalls: 1
- Cited as a predicate by: 2 devices
The OneTouch® Verio™ IQ Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, forearm or palm. The OneTouch® Verio™ IQ Blood Glucose Monitoring System is intended to be used by a single patient and should not be used for testing multiple patients.
- One Touch Verio Blood Glucose Monitoring SystemK093745 · Lifescan, Inc. · Feb 11, 2011
- Onetouch Verio Blood Glucose Monitoring SystemK131363 · Cilag GmbH International · Aug 30, 2013
- Onetouch Reveal Diabetes Management ApplicationK120558 · Lifescan, Inc. · Feb 7, 2013
| Started | Recall | Status |
|---|---|---|
| Feb 21, 2012 | Z-1359-2012An error was discovered in the OneTouch IQ meter software so that the meter turns itself off when a user attempts to view results in the "Results Log" when the log has 256 or a multiple of 256 items to display. | Terminated |
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 4, 2011
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files